Sharon Keiser

Imitators of Severe Pre-eclampsia

Interpretation of random effects meta-analyses

Physiological changes in pregnancy

Pre-eclampsia

Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators

Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia)

Dynamics of effector and naïve Regulatory T cells throughout pregnancy

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy

Recombinant Vascular Endothelial Growth Factor 121 Attenuates Autoantibody-Induced Features of Pre-eclampsia in Pregnant Mice

Pre-eclampsia

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy

Early identification of women with HELLP syndrome who need plasma exchange after delivery

Cyclo-oxygenase (COX) inhibitors for treating preterm labour

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Animal Models of Preeclampsia

Effect of antenatal tocolysis on neonatal outcomes

A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome

Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006

The Effect of Immune Factors, Tumor Necrosis Factor- , and Agonistic Autoantibodies to the Angiotensin II Type I Receptor on Soluble fms-Like Tyrosine-1 and Soluble Endoglin Production in Response to Hypertension During Pregnancy

Postpartum thrombotic microangiopathic syndrome

Standardized Mississippi Protocol Treatment of 190 Patients with HELLP Syndrome: Slowing Disease Progression and Preventing New Major Maternal Morbidity